What is MaxCyte's change in AR?

MaxCyte (MXCT) reported change in AR of $743K in Q1 2026.

How has MaxCyte's change in AR changed year-over-year?

MaxCyte's change in AR decreased by 11.4% year-over-year, from $839K to $743K.

What is the long-term trend for MaxCyte's change in AR?

Over 3 years (2021 to 2025), MaxCyte's change in AR has grown at a -12.4% compound annual growth rate (CAGR), from $1.71M to -$1.15M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

MaxCyte MXCT Change in AR

Change in AR at other companies

Ginkgo BioworksDNA

$242K-63.7%

Rapid Micro BiosystemsRPID

$3.23M+208%

RepligenRGEN

-$3.19M-132%

Prime MedicinePRME

$0-100%

Envista Holdings CorporationNVST

$13.3M-37.6%

BioSig Technologies, Inc.STEX

-$11K—

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's change in AR?: MaxCyte (MXCT) reported change in AR of $743K in Q1 2026.
How has MaxCyte's change in AR changed year-over-year?: MaxCyte's change in AR decreased by 11.4% year-over-year, from $839K to $743K.
What is the long-term trend for MaxCyte's change in AR?: Over 3 years (2021 to 2025), MaxCyte's change in AR has grown at a -12.4% compound annual growth rate (CAGR), from $1.71M to -$1.15M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.